Portage Biotech Inc.

NASDAQ: PRTG · Real-Time Price · USD
8.55
-0.25 (-2.84%)
At close: Aug 15, 2025, 3:59 PM
8.57
0.23%
After-hours: Aug 15, 2025, 07:52 PM EDT

Portage Biotech Income Statement

Financials in USD. Fiscal year is April - March.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Mar 31, 2024 Mar 31, 2023 Mar 31, 2022 Mar 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
54K 1K n/a n/a
Gross Profit
-54K -1K n/a n/a
Operating Income
-18.25M -16.57M -15.59M -12.44M
Interest Income
274K 217K 43.00 177.00
Pretax Income
-85.7M -122.52M -14.82M -14.89M
Net Income
-75.34M -104.61M -16.87M -15.83M
Selling & General & Admin
5.66M 8.36M 8.82M 5.13M
Research & Development
12.54M 8.21M 6.77M 7.31M
Other Expenses
n/a 1K n/a n/a
Operating Expenses
18.2M 16.58M 15.59M 12.44M
Interest Expense
32K 9K 43K 177K
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
18.25M 16.58M 15.59M 12.44M
Income Tax Expense
-10.55M -17.86M 4.35M 2.3M
Shares Outstanding (Basic)
20.34M 16.12M 13.06M 11.73M
Shares Outstanding (Diluted)
20.34M 16.12M 13.06M 11.73M
EPS (Basic)
-3.7 -6.49 -1.29 -1.35
EPS (Diluted)
-3.7 -6.49 -1.29 -1.35
EBITDA
-18.2M -15.78M -15.59M -14.19M
EBIT
-18.25M -15.78M -14.71M -14.22M
Depreciation & Amortization
54K 1K 15.59M 12.24M